ZonMw and Zorginstituut Nederland release “Veelbelovende Zorg” subsidy for research and care of medical innovations to be allowed in the standard care package

ZonMw and Zorginstituut Nederland release “Veelbelovende Zorg” subsidy for research and care of medical innovations to be allowed in the standard care package

25-02-2019

Last week Catalyze attended the information day for the new call “Veelbelovende Zorg”, tender released by a collaboration of ZonMW and ZIN. This tender is the next program following on the “Voorwaardelijk Toelating”. The aim of the tender is to assist in the uptake of medical technologies and medication in the reimbursement model for standard care in the Netherlands. The focus is on medical technology, medical devices, ATMPs and off-label medication.

Projects in this call

A typical project will investigate the efficiency of a new technology with the aim of being added to the standard care package of the reimbursement model in the Netherlands. The bottleneck in your project must be the costs for providing care to patients before it is accepted as standard care in the reimbursement model. An average project will obtain €4.5 million and can take maximum 6 years. After the project ends an application can be submitted to be added to the standard care reimbursement model at Zorginstituut Nederland. Before the start of the project the safety and effectiveness have to be proved and (if applicable) CE marking has to be obtained. Minimal 80% of the costs of the project must be the reimbursement of the use of the technology for the patient. Maximal 20% of the budget is eligible for additional research related costs.

Applications to this subsidy

The application must be submitted by the care provider and follows a 2 stage submission. First you submit a project idea before the deadline of 14 May 2019. Halfway August an advice will be given whether a full proposal should be submitted. The deadline for submission of full proposal is 22 October. Reviewers will provide their feedback and questions to applicants half November, providing applicants to reply to this until early December. The final decision about winning proposals will be communicated 22 March latest. Resubmission is allowed, so in case of rejection, you can resubmit for the next deadline.

The yearly budget is €69 million and will be divided over two rounds per year. The first round has a total budget of €40 million.

zonmw logo

You can find more information about this subsidy on the website of ZonMw

Photo by Ani Kolleshi on Unsplash

Labonovum – simplifying laboratory analysis for patients

Labonovum – simplifying laboratory analysis for patients

Interview with Dennis Poland, Chief Innovation Officer (CIO) of Labonovum novum (plural novums or nova) A new feature, a novelty. Despite great advancements in clinical analysis laboratory for the past half century, not much has changed for patients – who still have to endure the same procedures to collect blood for analysis. Labonovum has recently been awarded €3 million with… Continue Reading

Press Release: iPSpine Kick-off Meeting

Press Release: iPSpine Kick-off Meeting

Amsterdam, 13 February 2019 On February 12th and 13th, the kick-off of an international, 15-million-euro, 20-partner project titled iPSpine (Induced pluripotent stem cell-based therapy for spinal regeneration) was held in Utrecht, The Netherlands. This 5-year project falls under the European Union’s Horizon 2020 programme to fund research that improves knowledge, testing, and exploitation platforms that address… Continue Reading

Catalyze and Health Valley announce strategic partnership to bring innovations to patients faster

Catalyze and Health Valley announce strategic partnership to bring innovations to patients faster

Amsterdam, 30 January 2019 Catalyze – a market leader in obtaining funding for life science innovations – joins forces with the healthcare innovation network Health Valley, in a strategic partnership aimed at bringing innovations to patients faster. Health Valley is the largest network of healthcare innovations in the Netherlands. Within the Health Valley network, companies,… Continue Reading

Accelerating Swiss innovations to market with strategic collaboration

Accelerating Swiss innovations to market with strategic collaboration

Amsterdam, 29 January 2019 Catalyze announces collaboration with Biopôle, providing dedicated services to members towards better access to non-dilutive funding opportunities. Catalyze is an expert in obtaining non-dilutive funding for life science innovations. Catalyze provides clients and partners with the necessary help in obtaining funding for their R&D projects, supporting them as well with services… Continue Reading

iPSpine – the veterinarian trying to solve the problem of low back pain

iPSpine – the veterinarian trying to solve the problem of low back pain

Interview with Professor Marianna Tryfonidou, from the Faculty of Veterinary Medicine of the Utrecht University The iPSpine project was recently awarded €15 million under the Horizon 2020 programme, towards researching a solution for chronic lower back pain. The huge public-private consortium is comprised of 20 partners, and is coordinated by the Faculty of Veterinary Medicine… Continue Reading

Financial aid for Danish applicants to European research and innovation: EUopSTART

Financial aid for Danish applicants to European research and innovation: EUopSTART

14-12-2018 Danish SMEs looking to apply to European research and innovation programmes can receive financial aid to prepare their grant application, including expenses in external assistance. With the EUopSTART programme, you can receive funding for external assistance to your application to programmes such as ERC, SME Instrument, Fast Track to Innovation and Eurostars. EUopSTART The… Continue Reading

Thinking about starting your own biotech company?

Thinking about starting your own biotech company?

12-12-2018 by Benjamin Sieters You are an academic researcher with a brilliant idea or some very promising results in your recent experiments. Now you’re thinking of starting your own biotech company to actually bring your invention from the lab to the market. Making the step from academic research to biotech entrepreneurship Here are some aspects… Continue Reading

Need to assess the technical and commercial feasibility of your innovation?

Need to assess the technical and commercial feasibility of your innovation?

29-11-2018 by Saharla Ahmed Are you an SME with a ground-breaking concept, but unsure of its commercial potential? Do you have a platform technology and need to identify new and marketable applications to boost the growth of your company? An initial business plan that needs further elaboration? If so, a feasibility study is key to… Continue Reading

Added value Catalyze

Why choose Catalyze?


Scientific & academic

experts

Team of consultants with scientific and academic excellence (PhD, MD)

Commercial

experts

Consultants with experience in translating research into commercial products

Life sciences

biotechnology

Specialized in life sciences, biotechnology and medical technology.

Strong

network

Strong network of reliable and professional partners in the field.

 

Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or